Search research articles
Contact Us
Filters
Showing results (931-940 of 1,089) with videos related to
Page
of 109
Sort By:
Plos Genetics
|
November 8, 2018
Evidence that regulation of intramembrane proteolysis is mediated by substrate gating during sporulation in Bacillus subtilis
Fernando H Ramírez-Guadiana, Christopher D A Rodrigues, Kathleen A Marquis, et al.
Nature Chemical Biology
|
April 20, 2023
The relaxin receptor RXFP1 signals through a mechanism of autoinhibition
Sarah C Erlandson, Shaun Rawson, James Osei-Owusu, et al.
American Journal of Clinical Oncology
|
October 16, 1999
Paclitaxel and G-CSF in previously untreated patients with extensive stage small-cell lung cancer: a phase II study of the North Central Cancer Treatment Group
R J Kirschling, J P Grill, R S Marks, et al.
Drug Design and Discovery
|
April 1, 1996
Hydrophobic D-amino acids in the design of peptide ligands for the pp60src SH2 domain
M S Plummer, E A Lunney, K S Para, et al.
Genome Biology
|
August 10, 2005
MicroRNA profiling of the murine hematopoietic system
Silvia Monticelli, K Mark Ansel, Changchun Xiao, et al.
American Journal of Clinical Oncology
|
January 22, 2002
A phase II trial of edatrexate, vinblastine, adriamycin, cisplastin, and filgrastim (EVAC/G-CSF) in patients with non-small-cell carcinoma of the lungs: a North Central Cancer Treatment Group Trial
G Colon-Otero, R D Niedringhaus, S H Hillman, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
November 4, 2009
Endpoints in phase II trials for advanced non-small cell lung cancer
Sumithra J Mandrekar, Yingwei Qi, Shauna L Hillman, et al.
Cancer
|
April 30, 2009
Prognostic factors differ by tumor stage for small cell lung cancer: a pooled analysis of North Central Cancer Treatment Group trials
Nathan R Foster, Sumithra J Mandrekar, Steven E Schild, et al.
The Journal of Biological Chemistry
|
February 26, 2009
Melanoregulin (MREG) modulates lysosome function in pigment epithelial cells
Monika Damek-Poprawa, Tanja Diemer, Vanda S Lopes, et al.
European Review for Medical and Pharmacological Sciences
|
December 19, 2023
Unleashing the potential of biotechnology for sustainable development
K Donato, M C Medori, L Stuppia, et al.
Page
of 109
Search research articles
Search
Showing results (931-940 of 1,089) with videos related to
Sort By:
Page
of 109
Plos Genetics
|
November 8, 2018
Evidence that regulation of intramembrane proteolysis is mediated by substrate gating during sporulation in Bacillus subtilis
Fernando H Ramírez-Guadiana, Christopher D A Rodrigues, Kathleen A Marquis, et al.
Nature Chemical Biology
|
April 20, 2023
The relaxin receptor RXFP1 signals through a mechanism of autoinhibition
Sarah C Erlandson, Shaun Rawson, James Osei-Owusu, et al.
American Journal of Clinical Oncology
|
October 16, 1999
Paclitaxel and G-CSF in previously untreated patients with extensive stage small-cell lung cancer: a phase II study of the North Central Cancer Treatment Group
R J Kirschling, J P Grill, R S Marks, et al.
Drug Design and Discovery
|
April 1, 1996
Hydrophobic D-amino acids in the design of peptide ligands for the pp60src SH2 domain
M S Plummer, E A Lunney, K S Para, et al.
Genome Biology
|
August 10, 2005
MicroRNA profiling of the murine hematopoietic system
Silvia Monticelli, K Mark Ansel, Changchun Xiao, et al.
American Journal of Clinical Oncology
|
January 22, 2002
A phase II trial of edatrexate, vinblastine, adriamycin, cisplastin, and filgrastim (EVAC/G-CSF) in patients with non-small-cell carcinoma of the lungs: a North Central Cancer Treatment Group Trial
G Colon-Otero, R D Niedringhaus, S H Hillman, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
November 4, 2009
Endpoints in phase II trials for advanced non-small cell lung cancer
Sumithra J Mandrekar, Yingwei Qi, Shauna L Hillman, et al.
Cancer
|
April 30, 2009
Prognostic factors differ by tumor stage for small cell lung cancer: a pooled analysis of North Central Cancer Treatment Group trials
Nathan R Foster, Sumithra J Mandrekar, Steven E Schild, et al.
The Journal of Biological Chemistry
|
February 26, 2009
Melanoregulin (MREG) modulates lysosome function in pigment epithelial cells
Monika Damek-Poprawa, Tanja Diemer, Vanda S Lopes, et al.
European Review for Medical and Pharmacological Sciences
|
December 19, 2023
Unleashing the potential of biotechnology for sustainable development
K Donato, M C Medori, L Stuppia, et al.
Page
of 109